Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
about
Epigenetics in liver disease: from biology to therapeuticsCorrelation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.Circulating Tumor DNA as Biomarkers for Cancer Detection.DNA methylation patterns associated with oxidative stress in an ageing population.DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease.DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database.Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.The future of diagnosing NASH - could a simple blood test be the key?Epigenetics and allergy: from basic mechanisms to clinical applications.Dysregulation of redox pathways in liver fibrosis.Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.Epigenetic factors as drivers of fibrosis in systemic sclerosis.Epigenetics and Liver Fibrosis.Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.Hepatic stellate cells as key target in liver fibrosis.Cell-free DNA methylation as liquid biopsy for the assessment of fibrosis in patients with nonalcoholic steatohepatitis: a gap between innovation and implementation.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.Defining baseline epigenetic landscapes in the rat liver.Epigenetic reprogramming in liver fibrosis and cancer.A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis.DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity.Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis
P2860
Q28079271-48CB7A79-27F8-4B42-BA25-08058588CA66Q30355958-7EF4E693-FCCA-43E5-81A6-7ED51E330B93Q33632125-D1E4A52F-798F-4744-9854-D3BDF4224455Q36203565-E66C2A0F-F1B4-4CDA-94D0-58D2608C0919Q36871793-32CFC3A9-D980-425E-B872-82D122B3D979Q37556882-7A072839-B829-4E1E-8363-6C152320877CQ37673848-EE69C2F6-3277-475D-89EC-F28B2E348EF2Q38634380-F7DDD6C5-DFD7-4D86-AC3E-5DA3D817BDDAQ38742430-F22D0D48-9C53-4D53-885D-7E53C88844A0Q38937340-65FDB59F-9F1A-45A4-BBCB-CC8DC43180D9Q38985933-2ACF5B25-5A21-4877-975F-9C98732FAF20Q39003554-245A25BF-6F01-45E2-8C4E-2B65B19CBA19Q39200920-2B33E6A3-1A80-4641-8152-D7B3505474CBQ39358760-96C8C973-7FFD-488A-8B33-980119EAAFA7Q40121556-EA113C5D-922D-4212-952B-74121B96BC20Q40200602-6F07DDD7-464B-423E-BC8B-0AE7B4D9759EQ42356681-B8D8D9B8-3469-4868-B426-C20905F72F42Q45067817-F83EFEFE-4309-45C5-96C4-0C8F84EEDB52Q46213853-065A3FDF-04E5-44DB-B8AB-320C2553DF82Q46262957-B6473A9C-E00F-4F04-AB62-A967E6571BB6Q47157566-3B4D9BCA-80AB-4B8C-9F3A-54F4913019DEQ47264910-31986053-39B3-481F-B1C9-DAEFF5DE09F8Q48202101-E8C6D62E-02A3-419A-97FF-EEE6B0BC8994Q49788119-4C7493C2-6B5B-42EB-8C71-83818718881BQ52311728-17AA9C39-FD4F-4B17-A111-B0ED70696E13Q52644448-77697B1C-C9F1-48AB-84F3-F4FF6E7AF15FQ57147732-02CB0D69-5CAC-411B-9EF4-1AB183A9A176
P2860
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@ast
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@en
type
label
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@ast
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@en
prefLabel
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@ast
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@en
P2093
P2860
P50
P1433
P1476
Plasma DNA methylation: a pote ...... alcoholic fatty liver disease.
@en
P2093
Christian Dipper
Christopher P Day
Derek A Mann
Dina Tiniakos
Elsbeth Henderson
Jelena Mann
Jeremy French
Steve White
Steven Masson
Timothy Hardy
P2860
P304
P356
10.1136/GUTJNL-2016-311526
P407
P577
2016-03-21T00:00:00Z